New Insight into the Treatment of Advanced Differentiated Thyroid Cancer

Table 3

Ongoing comparative drugs trials in thyroid cancer.

Type of thyroid cancer	Intervention	Comparison	Expected end	Current status	Identifier
DTC*	Sorafenib	Placebo	Dec 2013	Ongoing, not recruiting	NCT00984282
DTC	Lenvatinib	Placebo	Jul 2013	Active, not recruiting	NCT01321554
DTC	Cediranib	Cediranib and lenalidomide	Sep 2013	Recruiting	NCT01208051
DTC, MTC**	Everolimus pasireotide	Everolimus or pasireotide	Jun 2014	Recruiting	NCT01270321

*DTC: differentiated thyroid cancer.
**MTC: medullary thyroid cancer.